Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

NCT03040024 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

71

Enrollment

OTHER

Sponsor class

Stopped Halted due to COVID 19; we believe we have adequate data for analysis

Conditions

Otolaryngeal Cancer

Interventions

DRUG: Ketamine
DRUG: Placebo
DEVICE: Electroencephalogram (EEG)

Sponsor

Emory University